90 related articles for article (PubMed ID: 2185822)
1. The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. World Health Organization. Task Force on Post-ovulatory Methods for Fertility Regulation.
Br J Obstet Gynaecol; 1990 Mar; 97(3):260-6. PubMed ID: 2185822
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
Henshaw RC; Templeton AA
Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
[TBL] [Abstract][Full Text] [Related]
3. Cervical ripening with mifepristone (RU 486) in late first trimester abortion. World Health Organization Task Force on Postovulatory Methods of Fertility Regulation.
Contraception; 1994 Nov; 50(5):461-75. PubMed ID: 7859455
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
Cohn M; Stewart P
Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
Durlot F; Dubois C; Brunerie J; Frydman R
Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
[TBL] [Abstract][Full Text] [Related]
6. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix.
Gupta JK; Johnson N
Lancet; 1990 May; 335(8700):1238-40. PubMed ID: 1971320
[TBL] [Abstract][Full Text] [Related]
7. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
Ashok PW; Flett GM; Templeton A
Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
[TBL] [Abstract][Full Text] [Related]
8. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study.
Ngai SW; Yeung KC; Lao T; Ho PC
Br J Obstet Gynaecol; 1996 Nov; 103(11):1120-3. PubMed ID: 8917000
[TBL] [Abstract][Full Text] [Related]
9. Controlled study of 16,16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal pessaries prior to suction termination of first trimester pregnancies.
Fisher PR; Taylor JH
Br J Obstet Gynaecol; 1984 Nov; 91(11):1141-4. PubMed ID: 6388625
[TBL] [Abstract][Full Text] [Related]
10. Cervical ripening with mifepristone (RU 486) in first trimester abortion. An electron microscope study.
Rådestad A; Thyberg J; Christensen NJ
Hum Reprod; 1993 Jul; 8(7):1136-42. PubMed ID: 8408500
[TBL] [Abstract][Full Text] [Related]
11. Induced cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study.
Rådestad A; Christensen NJ; Strömberg L
Contraception; 1988 Sep; 38(3):301-12. PubMed ID: 3168450
[TBL] [Abstract][Full Text] [Related]
12. Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy.
Carbonne B; Brennand JE; Maria B; Cabrol D; Calder AA
Br J Obstet Gynaecol; 1995 Jul; 102(7):553-8. PubMed ID: 7647058
[TBL] [Abstract][Full Text] [Related]
13. Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester.
Urquhart DR; Templeton AA
Contraception; 1990 Aug; 42(2):191-9. PubMed ID: 2085969
[TBL] [Abstract][Full Text] [Related]
14. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy.
Ngai SW; Tang OS; Lao T; Ho PC; Ma HK
Hum Reprod; 1995 May; 10(5):1220-2. PubMed ID: 7657769
[TBL] [Abstract][Full Text] [Related]
15. Induced cervical ripening with mifepristone (RU 486) and bioconversion of arachidonic acid in human pregnant uterine cervix in the first trimester. A double-blind, randomized, biomechanical and biochemical study.
Rådestad A; Bygdeman M; Green K
Contraception; 1990 Mar; 41(3):283-92. PubMed ID: 2182288
[TBL] [Abstract][Full Text] [Related]
16. [Oral administration of an antiprogesterone (Mifepristone, RU 486) for preparing the cervix uteri for pregnancy interruption during the first trimester].
De Grandi P; Giudici G
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):801-8. PubMed ID: 2689506
[TBL] [Abstract][Full Text] [Related]
17. Cervical softening with mifepristone (RU 486) after pretreatment with naproxen. A double-blind randomized study.
Rådestad A; Bygdeman M
Contraception; 1992 Mar; 45(3):221-7. PubMed ID: 1511608
[TBL] [Abstract][Full Text] [Related]
18. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?
Singh K; Fong YF; Prasad RN; Dong F
Hum Reprod; 1999 Jun; 14(6):1635-7. PubMed ID: 10357990
[TBL] [Abstract][Full Text] [Related]
19. Medical methods for first trimester abortion.
Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
Rodger MW; Baird DT
Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
